GeneDx Holdings Corp (OQ:WGS)

Business Focus: Medical & Diagnostic Laboratories

Latest 10 SEC filings (by transaction date) for WGS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 5th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 23/24 Jan 22/24 Saad Kareem Direct Ownership Class A Common Stock S - Open market or private sale -193 $3.24
Jan 23/24 Jan 19/24 Saad Kareem Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -546  
Jan 23/24 Jan 19/24 Saad Kareem Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 546  
Jan 12/24 Jan 11/24 Ryan Jason Direct Ownership Class A Common Stock G - Gift -73,614  
Jan 4/24 Jan 3/24 Saad Kareem Direct Ownership Class A Common Stock S - Open market or private sale -105 $2.58
Jan 3/24 Jan 1/24 Saad Kareem Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -273  
Jan 3/24 Jan 1/24 Saad Kareem Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 273  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -46,000  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -21,780  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 67,780  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for WGS within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 5th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 23/24 Jan 19/24 Saad Kareem Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -546  
Jan 23/24 Jan 22/24 Saad Kareem Direct Ownership Class A Common Stock S - Open market or private sale -193 $3.24
Jan 23/24 Jan 19/24 Saad Kareem Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 546  
Jan 12/24 Jan 11/24 Ryan Jason Direct Ownership Class A Common Stock G - Gift -73,614  
Jan 4/24 Jan 3/24 Saad Kareem Direct Ownership Class A Common Stock S - Open market or private sale -105 $2.58
Jan 3/24 Jan 1/24 Saad Kareem Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -273  
Jan 3/24 Jan 1/24 Saad Kareem Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 273  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -46,000  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Restricted Stock Unit M - Exercise or conversion exempt under rule 16b-3 -21,780  
Jan 3/24 Dec 31/23 Ryan Jason Direct Ownership Class A Common Stock M - Exercise or conversion exempt under rule 16b-3 67,780  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $WGS

  • No tweets found

Competitors

Competitors with Recent Insider Filings
OPKO Health (OQ:OPK)
Fulgent Genetics (OQ:FLGT)
Radnet (OQ:RDNT)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.